search
Back to results

Cognitive Behavioural Therapy for Insomnia for Chinese Adults: a RCT (CBTI)

Primary Purpose

Insomnia

Status
Unknown status
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Cognitive behavioural therapy for insomnia
Sponsored by
Hospital Authority, Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Insomnia focused on measuring Cognitive behaviour therapy, group treatment, insomnia

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Insomnia
  • Chinese aged 18-65 years old
  • Chinese reading and writing proficiency of primary school
  • Ability to give consent
  • Accept randomization

Exclusion Criteria:

  • substance abuse or dependence
  • manic or hypomanic episode
  • schizophrenia
  • personality disorders
  • posttraumatic stress disorder (PTSD)
  • mental retardation
  • organic mental disorder
  • Suicidal risk or a suicidal attempt in the past three months

Sites / Locations

  • Department of Clinical Psychology, New Territories East Cluster, Hospital AuthorityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Treatment arm

Waitlist control

Arm Description

Participants in the treatment group will show significant improvement on insomnia symptoms after intervention compared to those in the waitlist control group.

Participants in the waitlist control group will show little improvement on insomnia symptoms after the treatment period of the treatment group.

Outcomes

Primary Outcome Measures

Change in Insomnia Symptom Inventory (ISI) (Bastien et al, 2001)
A 7-item self-report questionnaire assessing the nature, severity and the impact of insomnia. Insomnia Symptom Inventory is the primary outcome measure. All items are assessed on a 5-point scale (0-4), with its total score ranging between 0 to 28. Higher score representing worse insomnia symptoms.

Secondary Outcome Measures

Change in Dysfunctional Beliefs about Sleep Scale (DBAS) (Morin et al, 2007)
A self-report questionnaire for evaluation of cognition, behaviours and attitudes related to insomnia. All items are assessed on a 5-point scale (0-4). Its total score ranged between 0 to 112, with higher score representing more dysfunctional beliefs about sleep.
Change in Patient Health Questionnaire 9 (PHQ-9) (Kroenke & Spitzer, 2002)
A 9-item self-report questionnaires for evaluation of depression. All items are assessed on a 4-point scale (0-3). Its total score ranged between 0 to 27, with higher score representing more severe depressive symptoms.
Change in Generalized Anxiety Disorder-7 item (GAD-7) Questionnaire (Spitzer et al, 2006)
A 7-item self-report questionnaires for evaluation of general anxiety. All items are assessed on a 4-point scale (0-3), with its total score ranging between 0 to 21. Higher score representing increased anxiety symptoms.
Change in Work and Social Adjustment Scale (WSAS) (Mundt et al, 2002)
A 5-item simple self-report measure of impairment in functioning. All items are assessed on a 9-point scale (0-8), with its total score ranging between 0 to 40. Higher score representing greater impairment in functioning

Full Information

First Posted
August 14, 2020
Last Updated
December 3, 2020
Sponsor
Hospital Authority, Hong Kong
search

1. Study Identification

Unique Protocol Identification Number
NCT04653155
Brief Title
Cognitive Behavioural Therapy for Insomnia for Chinese Adults: a RCT
Acronym
CBTI
Official Title
Cognitive Behavioural Therapy for Insomnia for Chinese Adults: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 1, 2020 (Actual)
Primary Completion Date
August 31, 2021 (Anticipated)
Study Completion Date
December 31, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Authority, Hong Kong

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: Insomnia is a common mental problem, where people experienced difficulty falling asleep, problem maintaining asleep and early morning awakening. It is highly prevalent world-wide and in Hong Kong, causing significant suffering and distress. While evidence based intervention exists, e.g. cognitive-behavioural therapy (CBT), there will not enough therapists to meet treatment demand. A more efficient delivery of treatment, e.g. internet based therapy is called for that can delivery treatment more cost efficiently by requiring lesser therapist time. Objective: This study aims at evaluating the effectiveness of CBTi (Gp) on treating Chinese insomniac adults in Hong Kong. There has been criticism that most clinical trials have been conducted with Caucasians in Western countries and little has been done with ethnic minorities, including Asians in these countries, not to mention Asians in Asian countries, e.g., Chinese in Hong Kong. Design: A two-arm parallel-group randomised controlled trial, comparing the treatment and waitlist group Method: A CBTi protocol would be developed. Approximately 60 Chinese adults with insomnia will be recruited in Hong Kong and randomised into one of the two groups (treatment vs. waitlist). The treatment last for 6 weeks, plus a 3-month follow-up period. The primary outcome measure will be Insomnia Severity Index (ISI).
Detailed Description
Insomnia is characterized by difficulty in initiating sleep, difficulty in maintaining sleep, early morning awakening and non-restorative sleep, which should be relatively frequent (>/= 3 times/ week), persistent (>/= 2-4 weeks) and severe enough to affect daytime functioning. It is among the most common mental disorders. Epidemiological surveys in Western countries found a high prevalence of insomnia syndrome (9.2-13%) and insomnia symptoms (11.4% to 38%). In Hong Kong, a prevalence of 11.9% was reported for community adults. Given such high prevalence, insomnia is evidently one major health concern across diverse communities, including Hong Kong. Furthermore, the disorder runs a chronic and debilitating course if untreated. Interrelationships between insomnia and mental health are now well established in the epidemiological literature, with insomnia shown to be frequently comorbid with mental health concerns, such as depression or anxiety and risk of suicide. Insomnia symptoms have repeatedly been shown to increase the risk of subsequent depression. Also, it is shown that augmenting an antidepressant medication with a brief, symptom focused, cognitive-behavioral therapy for insomnia is promising for individuals with depression and comorbid insomnia in terms of alleviating both depression and insomnia. It is clear that insomnia is not only a disorder of high personal suffering, but is also associated with high and recurring societal costs. These facts strongly argue for the need of effective treatments to relieve personal suffering, caring burdens, and societal economic costs. Fortunately, there are effective treatments available for insomnia, particularly cognitive-behavioural therapy (CBT). In a number of meta-analysis of insomnia treatments, CBT is effective and consistently performs better than placebo and other control conditions in improving nighttime insomnia symptoms, including sleep latency, total sleep time, wake after sleep onset, and insomnia symptoms. CBT for insomnia (CBTi) packages include stimulus control, relaxation, sleep restriction and their combination meet APA criteria for empirically validated treatment for insomnia based on the strength of results from a number of empirical studies. Unfortunately, while effective psychological treatments exist, there is only limited manpower to provide the intervention. Western studies showed that 15-25% of children and adults were suffering from mental health disorders, but only 20-30% of them had access to treatment. Locally in Hong Kong, we are facing an almost identical situation. About 15% of children and adults suffered from mental health disorders, but again only 15-30% of them had access to mental health services. Obviously, a shortage of mental health professionals such as psychiatrists or clinical psychologists is a worldwide phenomenon. In Hong Kong, our situation regarding the availability of clinical psychologists (CPs) in providing psychological treatment is even worse. We have a ratio of approximately 1 CP to 18,000 in the Hong Kong population, far below the ratio of 1 in 3,500 in the USA. Most governments, including those of richer countries like USA, will admit that they will never have the resources to increase the number of mental health professionals like psychiatrists and CPs to meet the societal demand. Instead, a more viable solution is to look for greater cost-efficiency in delivering services. Recent meta-analyses find the effectiveness of group psychological treatment (mostly CBT) for insomnia as largely comparable to that of traditional one on one therapy. Group therapy is thus advocated as a less-intensive, cost-effective way to offer evidence-based treatment. Based on Morin, we developed a treatment protocol for CBTi, incorporating both education and individualized feedback. The protocol implements all of the key procedures in one-on-one CBTi such as sleep restriction, stimulus control, managing dysfunctional beliefs about sleep, behavioural experiments, increasing energizing behaviours, all of which target the maintaining factors of insomnia. Patients would be assigned a therapist to follow up on them via either brief (5-10 minutes) telephone calls. Compared to traditional face to face CBTi, the protocol requires 32% of the therapist's time of the latter, i.e., a 68% drop in the therapist's time. There is a paucity of study in the effectiveness of cognitive behaviour therapy for insomnia in Hong Kong Chinese, let alone CBTi in group. This proposal aims at developing a CBTi protocol for treatment of insomnia in Hong Kong to increase the access of evidence-based treatment to local Chinese insomnia adults. This involves protocol development, test-run and a randomized controlled trial (RCT) with a waitlist control group and a short-term follow-up of three months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insomnia
Keywords
Cognitive behaviour therapy, group treatment, insomnia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment arm
Arm Type
Experimental
Arm Description
Participants in the treatment group will show significant improvement on insomnia symptoms after intervention compared to those in the waitlist control group.
Arm Title
Waitlist control
Arm Type
No Intervention
Arm Description
Participants in the waitlist control group will show little improvement on insomnia symptoms after the treatment period of the treatment group.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive behavioural therapy for insomnia
Intervention Description
Cognitive behavioural therapy for insomnia
Primary Outcome Measure Information:
Title
Change in Insomnia Symptom Inventory (ISI) (Bastien et al, 2001)
Description
A 7-item self-report questionnaire assessing the nature, severity and the impact of insomnia. Insomnia Symptom Inventory is the primary outcome measure. All items are assessed on a 5-point scale (0-4), with its total score ranging between 0 to 28. Higher score representing worse insomnia symptoms.
Time Frame
Change from baseline Insomnia Symptom Inventory at 3 months
Secondary Outcome Measure Information:
Title
Change in Dysfunctional Beliefs about Sleep Scale (DBAS) (Morin et al, 2007)
Description
A self-report questionnaire for evaluation of cognition, behaviours and attitudes related to insomnia. All items are assessed on a 5-point scale (0-4). Its total score ranged between 0 to 112, with higher score representing more dysfunctional beliefs about sleep.
Time Frame
Change from baseline Dysfunctional Beliefs about Sleep Scale at 3 months
Title
Change in Patient Health Questionnaire 9 (PHQ-9) (Kroenke & Spitzer, 2002)
Description
A 9-item self-report questionnaires for evaluation of depression. All items are assessed on a 4-point scale (0-3). Its total score ranged between 0 to 27, with higher score representing more severe depressive symptoms.
Time Frame
Change from baseline Patient Health Questionnaire 9 (PHQ-9) at 3 months
Title
Change in Generalized Anxiety Disorder-7 item (GAD-7) Questionnaire (Spitzer et al, 2006)
Description
A 7-item self-report questionnaires for evaluation of general anxiety. All items are assessed on a 4-point scale (0-3), with its total score ranging between 0 to 21. Higher score representing increased anxiety symptoms.
Time Frame
Change from baseline Generalized Anxiety Disorder-7 item (GAD-7) Questionnaire at 3 months
Title
Change in Work and Social Adjustment Scale (WSAS) (Mundt et al, 2002)
Description
A 5-item simple self-report measure of impairment in functioning. All items are assessed on a 9-point scale (0-8), with its total score ranging between 0 to 40. Higher score representing greater impairment in functioning
Time Frame
Change from baseline Work and Social Adjustment Scale at 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Insomnia Chinese aged 18-65 years old Chinese reading and writing proficiency of primary school Ability to give consent Accept randomization Exclusion Criteria: substance abuse or dependence manic or hypomanic episode schizophrenia personality disorders posttraumatic stress disorder (PTSD) mental retardation organic mental disorder Suicidal risk or a suicidal attempt in the past three months
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Amy Kwok, PhD
Phone
+852 39197716
Email
kwokpl@ha.org.hk
Facility Information:
Facility Name
Department of Clinical Psychology, New Territories East Cluster, Hospital Authority
City
Hong Kong
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Amy Kwok, PhD
Phone
3919 7716
Email
kwokpl@ha.org.hk

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Cognitive Behavioural Therapy for Insomnia for Chinese Adults: a RCT

We'll reach out to this number within 24 hrs